<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/PmJ1609-1175.2018.4.41-45</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-281</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Иммунные комплексы и их роль в активации иммунитета при ВИЧ-инфекции</article-title><trans-title-group xml:lang="en"><trans-title>Immune complexes and their role in activation of immunity in HIV-infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Королевская</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Korolevskaya</surname><given-names>L. B.</given-names></name></name-alternatives><email xlink:type="simple">bioqueen@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сайдакова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Saydakova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шмагель</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shmagel</surname><given-names>K. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шмагель</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Shmagel</surname><given-names>N. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Пермский федеральный исследовательский центр УрО РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Perm Scientific Centre of the Ural Branch of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Пермский федеральный исследовательский центр УрО РАН; Пермский краевой центр по профилактике и борьбе со СПИД и инфекционными заболеваниями</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Perm Scientific Centre of the Ural Branch of the Russian Academy of Sciences; AIDS Prevention Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2018</year></pub-date><volume>0</volume><issue>4</issue><fpage>41</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Королевская Л.Б., Сайдакова Е.В., Шмагель К.В., Шмагель Н.Г., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Королевская Л.Б., Сайдакова Е.В., Шмагель К.В., Шмагель Н.Г.</copyright-holder><copyright-holder xml:lang="en">Korolevskaya L.B., Saydakova E.V., Shmagel K.V., Shmagel N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/281">https://www.tmj-vgmu.ru/jour/article/view/281</self-uri><abstract><p>У 30 ВИЧ-инфицированных пациентов определено содержание циркулирующих иммунных комплексов (ЦИК) и относительное количество активированных Т-лимфоцитов. Установлены прямые корреляционные связи между концентрацией ЦИК и активацией Т-клеток. Исследована роль иммунных комплексов, содержащих антигены ВИЧ и противовирусные антитела, в активации клеток врожденного иммунитета. Выявлено, что стимуляция мононуклеаров неифицирован-ных доноров такими иммунными агрегатами приводит к усилению генерации кислорода и значительному увеличению относительного количества СD14+-клеток, синтезирующих интерлейкин-6. По-видимому, иммунные комплексы могут считаться еще одним из факторов активации иммунитета при ВИЧ-инфекции.</p></abstract><trans-abstract xml:lang="en"><p>Objective. Immune activation is the main predictor of the progression of infection caused by the human immunodeficiency virus (HIV). The reasons remain incomprehensible and, probably, can be multifactorial. We suggest that immune complexes are also capable of stimulating immunocompetent cells. Methods. We examined 30 HIV-infected patients who had concentrations of circulating immune complexes and the relative amount of activated T-lymphocytes. In vitro interaction of mononuclear cells of peripheral blood of uninfected donors with immune complexes containing HIV-antigens and antiviral antibodies. Results. It was found that the concentration of circulating immune complexes is directly related to the activation of T-lymphocytes. It has been shown that the interaction of mononuclear cells of healthy donors with immune complexes leads to a significant increase in the proportion of CD14+ monocytes producing interleukin-6 and to enhance the production of reactive oxygen species. Conclusions. Immune complexes containing HIV-antigens and antiviral antibodies are able to activate immunocompetent cells. Such complexes may be another factor in the activation of immunity in HIV-infection.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>вирус иммунодефицита человека</kwd><kwd>активация иммунокомпетентных клеток</kwd><kwd>циркулирующие иммунные комплексы</kwd><kwd>активированные Т-лимфоциты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>human immunodeficiency virus</kwd><kwd>immunocompetent cells activation</kwd><kwd>circulating immune complexes</kwd><kwd>activated</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson C.F., Mosser D.M. A novel phenotype for an activated macrophage: the type 2 activated macrophage // J. Leuk. Biology. 2002. Vol. 72, No. 1. P. 101-106.</mixed-citation><mixed-citation xml:lang="en">Anderson C.F., Mosser D.M. A novel phenotype for an activated macrophage: the type 2 activated macrophage // J. Leuk. Biology. 2002. Vol. 72, No. 1. P. 101-106.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bastidas S., Graw F., Smith M.Z. [et al.]. CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals // J. Immunol. 2014. Vol. 192, No. 4. P. 1732-1744.</mixed-citation><mixed-citation xml:lang="en">Bastidas S., Graw F., Smith M.Z. [et al.]. CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals // J. Immunol. 2014. Vol. 192, No. 4. P. 1732-1744.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Biancotto A., Grivel J.C., Iglehart S.J. [et al.]. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1 // Blood. 2007. Vol. 109, No. 10. P. 4272-4279.</mixed-citation><mixed-citation xml:lang="en">Biancotto A., Grivel J.C., Iglehart S.J. [et al.]. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1 // Blood. 2007. Vol. 109, No. 10. P. 4272-4279.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Brenchley J.M., Price D.A., Schacker T.W. [et al.]. Microbial translocation is a cause of systemic immune activation in chronic HIV infection // Nat. Med. 2006. Vol. 12, No. 12. P 1365-1371.</mixed-citation><mixed-citation xml:lang="en">Brenchley J.M., Price D.A., Schacker T.W. [et al.]. Microbial translocation is a cause of systemic immune activation in chronic HIV infection // Nat. Med. 2006. Vol. 12, No. 12. P 1365-1371.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Catalfamo M., Wilhelm C., Tcheung L. [et al.]. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7 // J. Immunol. 2011. Vol. 186, No. 4. P 2106-2116.</mixed-citation><mixed-citation xml:lang="en">Catalfamo M., Wilhelm C., Tcheung L. [et al.]. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7 // J. Immunol. 2011. Vol. 186, No. 4. P 2106-2116.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Eggena M.P, Barugahare B., Jones N. [et al.]. Depletion of regulatory T cells in HIV infection is associated with immune activation // J. Immunol. 2005. Vol. 174, No. 7. P. 4407-4414.</mixed-citation><mixed-citation xml:lang="en">Eggena M.P, Barugahare B., Jones N. [et al.]. Depletion of regulatory T cells in HIV infection is associated with immune activation // J. Immunol. 2005. Vol. 174, No. 7. P. 4407-4414.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Garcia E., Rosales C. Fc receptor signaling in leukocytes: Role in host defense and immune regulation // Current Immunology Reviews. 2009. Vol. 5. P. 227-242.</mixed-citation><mixed-citation xml:lang="en">Garcia-Garcia E., Rosales C. Fc receptor signaling in leukocytes: Role in host defense and immune regulation // Current Immunology Reviews. 2009. Vol. 5. P. 227-242.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Guilliams M., Bruhns P, Saeys Y. [et al.]. The function of Fcgamma receptors in dendritic cells and macrophages // Nat. Rev. Immunol. 2014. Vol. 14, No. 2. P. 94-108.</mixed-citation><mixed-citation xml:lang="en">Guilliams M., Bruhns P, Saeys Y. [et al.]. The function of Fcgamma receptors in dendritic cells and macrophages // Nat. Rev. Immunol. 2014. Vol. 14, No. 2. P. 94-108.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hazenberg M.D., Otto S.A., van Benthem B.H. [et al.]. Persistent immune activation in HIV-1 infection is associated with progression to AIDS // AIDS. 2003. Vol. 17, No. 13. P. 1881-1888.</mixed-citation><mixed-citation xml:lang="en">Hazenberg M.D., Otto S.A., van Benthem B.H. [et al.]. Persistent immune activation in HIV-1 infection is associated with progression to AIDS // AIDS. 2003. Vol. 17, No. 13. P. 1881-1888.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kuri-Cervantes L., de Oca G.S., Avila-Rios S. [et al.]. Activation of NK cells is associated with HIV-1 disease progression // J. Leukoc. Biol. 2014. Vol. 96, No. 1. P. 7-16.</mixed-citation><mixed-citation xml:lang="en">Kuri-Cervantes L., de Oca G.S., Avila-Rios S. [et al.]. Activation of NK cells is associated with HIV-1 disease progression // J. Leukoc. Biol. 2014. Vol. 96, No. 1. P. 7-16.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Liu P., Overman R.G., Yates N.L. [et al.]. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection // J. Virol. 2011. Vol. 85, No. 21. P. 11196-11207.</mixed-citation><mixed-citation xml:lang="en">Liu P., Overman R.G., Yates N.L. [et al.]. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection // J. Virol. 2011. Vol. 85, No. 21. P. 11196-11207.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Moir S., Fauci A.S. B cells in HIV infection and disease // Nat. Rev. Immunol. 2009. Vol. 9, No. 4. P. 235-245.</mixed-citation><mixed-citation xml:lang="en">Moir S., Fauci A.S. B cells in HIV infection and disease // Nat. Rev. Immunol. 2009. Vol. 9, No. 4. P. 235-245.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Paiardini M., Muller-Trutwin M. HIV-associated chronic immune activation // Immunological Reviews. 2013. Vol. 254. P. 78-101.</mixed-citation><mixed-citation xml:lang="en">Paiardini M., Muller-Trutwin M. HIV-associated chronic immune activation // Immunological Reviews. 2013. Vol. 254. P. 78-101.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rosales C. Fc-gamma receptor heterogeneity in leukocyte functional responses // Front. Immunol. 2017. Vol. 8. P. 280.</mixed-citation><mixed-citation xml:lang="en">Rosales C. Fc-gamma receptor heterogeneity in leukocyte functional responses // Front. Immunol. 2017. Vol. 8. P. 280.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tanaka M., Krutzik S.R., Sieling P.A. [et al.]. Activation of Fc RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses // J. Immunol. 2009. Vol. 183. P. 2349-2355.</mixed-citation><mixed-citation xml:lang="en">Tanaka M., Krutzik S.R., Sieling P.A. [et al.]. Activation of Fc RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses // J. Immunol. 2009. Vol. 183. P. 2349-2355.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
